BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jannier S, Kemmel V, Sebastia Sancho C, Chammas A, Sabo AN, Pencreach E, Farace F, Chenard MP, Lhermitte B, Geoerger B, Aerts I, Frappaz D, Leblond P, André N, Ducassou S, Corradini N, Bertozzi AI, Guérin E, Vincent F, Velten M, Entz-Werle N. SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers. Cancers (Basel) 2020;12:E3051. [PMID: 33092063 DOI: 10.3390/cancers12103051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sabo AN, Jannier S, Becker G, Lessinger JM, Entz-Werlé N, Kemmel V. Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology. Pharmaceutics 2021;13:470. [PMID: 33808416 DOI: 10.3390/pharmaceutics13040470] [Reference Citation Analysis]
2 Seo SH, Paul SK, Shikder M, Khanam M, Ghosh P, Hasib TA, Ahmed KA, Sikdar S, Uddin MJ, Kwon Y. An Insight into Pathophysiological Features and Therapeutic Advances on Ependymoma. Cancers (Basel) 2021;13:3221. [PMID: 34203272 DOI: 10.3390/cancers13133221] [Reference Citation Analysis]